How I use microablative fractional radiofrequency (MAFRF) to treat lichen sclerosus
DOI:
https://doi.org/10.5327/2237-4574-2024820015Keywords:
lichen sclerosus, radiofrequency therapy, vulvar diseasesAbstract
Lichen sclerosus is a chronic, inflammatory skin disease that affects the vulvar and perianal regions, causing intense pruritus and
vulvar atrophy, with carcinogenic potential when adequately treated. Its main histological characteristics include hyalinization
of collagen fibers and lichenoid inflammatory infiltrate. Conventional treatment is based on the use of high-potency topical
corticosteroids for an extended period, aiming to control pruritus, anatomical deformities and malignant progression.
However, long-term use of this medication can induce vulvar atrophy, dry skin, telangiectasias and secondary infections.
Therefore, adjuvant treatments may be useful in reducing these side effects. Microablative fractional radiofrequency (MAFRF)
has already been used in cosmetic skin treatments that seek to improve skin tropism through remodeling and stimulation of
collagen synthesis. Therefore, this type of energy can be used as an adjuvant tool by increasing the production of collagen and
elastin, improving epithelial trophism and consequently itching, burning and hypochromia, with a direct impact on affected
patients’ sexual life’s quality and self-esteem.
References
Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet
Gynecol. 2005;48(4):808-17. https://doi.org/10.1097/01.
grf.0000179635.64663.3d
De Luca DA, Papara C, Vorobyev A, Staiger H, Bieber K, Thaçi D,
et al. Lichen sclerosus: the 2023 update. Front Med (Lausanne).
;10:1106318. https://doi.org/10.3389/fmed.2023.1106318
Pérez-López FR, Vieira-Baptista P. Lichen sclerosus in
women: a review. Climacteric. 2017;20(4):339-47. https://doi.
org/10.1080/13697137.2017.FISTAROL
Mautz TT, Krapf JM, Goldstein AT. Topical corticosteroids in the
treatment of vulvar lichen sclerosus: a review of pharmacokinetics
and recommended dosing frequencies. Sex Med Rev. 2022;10(1):42-
https://doi.org/10.1016/j.sxmr.2021.03.006
Lee A, Bradford J, Fischer G. Long-term management of adult
vulvar lichen sclerosus: a prospective cohort study of 507 women.
JAMA Dermatol. 2015;151(10):1061-7. https://doi.org/10.1001/
jamadermatol.2015.0643
Kamilos MF, Aguiar LM, Batista VH, Roa CL, Aguiar FN, Soares Júnior
JM, et al. Microablative fractional radiofrequency as a therapeutic
option for vulvar lichen sclerosus: a pilot study. Clinics (Sao Paulo).
;76:e2567. https://doi.org/10.6061/clinics/2021/e2567
Prignano F, Campolmi P, Bonan P, Ricceri F, Cannarozzo G, Troiano
M, et al. Fractional CO2
laser: a novel therapeutic device upon
photobiomodulation of tissue remodeling and cytokine pathway
of tissue repair. Dermatol Ther. 2009;22 Suppl 1:S8-15. https://doi.
org/10.1111/j.1529-8019.2009.01265.x
Maness WL, Roeber FW, Clark RE, Cataldo E, Riis D, Haddad AW.
Histologic evaluation of electrosurgery with varying frequency
and waveform. J Prosthet Dent. 1978;40(3):304-8. https://doi.
org/10.1016/0022-3913(78)90037-9
Fistonić I, Turina ISB, Fistonić N, Marton I. Short time efficacy and
safety of focused monopolar radiofrequency device for labial laxity
improvement-noninvasive labia tissue tightening. A prospective cohort
study. Lasers Surg Med. 2016;48(3):254-9. https://doi.org/10.1002/
lsm.22450
